BiotechTube
Home/Coherus BioSciences/Dennis M. Lanfear
DM

Dennis M. Lanfear

President, Chief Executive Officer, and Chairman of the Board

Coherus BioSciences

Roles

President, Chief Executive Officer, and Chairman of the BoardatCoherus BioSciences
President & Chief Executive Officer, Chairman of the BoardatCoherus Oncology

Therapeutic Areas

OncologyImmunologyInflammatory Diseases

Coherus BioSciences Pipeline

DrugIndicationPhase
UDENYCA® (pegfilgrastim-cbqv)Neutropenia in patients receiving myelosuppressive chemotherapyApproved
YUSIMRY™ (adalimumab-aqvh)Rheumatoid Arthritis, Psoriasis, Crohn's Disease, and other inflammatory conditionsApproved
Toripalimab1L recurrent or metastatic nasopharyngeal carcinoma (NPC)BLA Submitted
CHS-006Advanced solid tumorsPhase 1
CHS-1000Advanced solid tumorsPreclinical
CHS-1020Advanced solid tumorsPreclinical

Leadership Team at Coherus BioSciences

BM
Bryan McMichael
Chief Financial Officer
TL
Theresa LaVallee
Chief Development Officer
PR
Paul Reider
Chief Commercial Officer
MS
McDavid Stilwell
Chief Corporate Affairs & Communications Officer
PK
Paul Kang
General Counsel
BK
Barbara K. Finck
Chief Medical Officer
VL
Vicki L. Sato
Board Member
BD
Barbara D. Duncan
Board Member
JO
James O. Armitage
Board Member
JG
John G. Gargiulo
Board Member
View full Coherus BioSciences profile